Holdings Information
The clinical practice of drug information / edited by Michael Gabay.
Bibliographic Record Display
-
Title:The clinical practice of drug information / edited by Michael Gabay.
-
Other Contributors/Collections:Gabay, Michael, editor.
-
Published/Created:Burlington, MA : Jones & Bartlett Learning, [2016]
-
Holdings
Holdings Record Display
-
Location:BMB LIBRARY (VGH) stacksWhere is this?
-
Call Number: QV737.1 .C641 2016
-
Number of Items:1
-
Status:Available
-
Location:WOODWARD LIBRARY stacksWhere is this?
-
Call Number: QV737.1 .C641 2016
-
Number of Items:1
-
Status:Available
-
Location:BMB LIBRARY (VGH) stacksWhere is this?
-
Library of Congress Subjects:Drugs.
Pharmacology.
Materia medica.
-
Medical Subjects: Drug Information Services.
Pharmaceutical Services.
-
Description:xxv, 511 pages : illustrations ; 26 cm
-
Summary:"This resource will educate students and pharmacists on traditional drug information topics while providing an extensive background on more recent practice areas. This is a user-friendly text with multiple examples that can be used in education and training, as well as clinical practice. Each chapter includes learning objectives, key terms, examples and cases, and review questions"-- Provided by publisher.
-
Notes:Includes bibliographical references and index.
-
ISBN:9781284026238 paperback
128402623X paperback
-
Contents:Machine generated contents note: Introduction / Andrea L. McKeever / Michael Gabay
History / Andrea L. McKeever / Michael Gabay
Practice Settings / Andrea L. McKeever / Michael Gabay
Pharmacy Curricular Instruction / Andrea L. McKeever / Michael Gabay
Residency Training / Andrea L. McKeever / Michael Gabay
Future Directions and Challenges / Andrea L. McKeever / Michael Gabay
Summary / Andrea L. McKeever / Michael Gabay
References / Andrea L. McKeever / Michael Gabay
Introduction / Christine K. Choy / Jamie N. Brown
Receive / Christine K. Choy / Jamie N. Brown
Receiving the Demographics of the Requestor / Christine K. Choy / Jamie N. Brown
Receiving the Background Information / Christine K. Choy / Jamie N. Brown
Receiving the Ultimate Question and Categorization / Christine K. Choy / Jamie N. Brown
Solicitation of Drug Information Requests Through Intermediaries / Christine K. Choy / Jamie N. Brown
Research / Christine K. Choy / Jamie N. Brown
Respond / Christine K. Choy / Jamie N. Brown
Record / Christine K. Choy / Jamie N. Brown
Legal and Ethical Considerations / Christine K. Choy / Jamie N. Brown
Continuous Quality Improvement / Christine K. Choy / Jamie N. Brown
Trainees: Pharmacy Students, Interns, and Postgraduate Residents / Christine K. Choy / Jamie N. Brown
Informal Drug Information Services / Christine K. Choy / Jamie N. Brown
Formal Drug Information Services / Christine K. Choy / Jamie N. Brown
Outcome Tracking / Christine K. Choy / Jamie N. Brown
Summary / Christine K. Choy / Jamie N. Brown
References / Christine K. Choy / Jamie N. Brown
Introduction / Vern Duba / Vicki R. Kee
Methods of Evaluation / Vern Duba / Vicki R. Kee
General References / Vern Duba / Vicki R. Kee
AHFS® Drug Information (DI)[™] / Vern Duba / Vicki R. Kee
Drug Facts and Comparisons® / Vern Duba / Vicki R. Kee
DRUGDEX® System / Vern Duba / Vicki R. Kee
Clinical Drug Data / Vern Duba / Vicki R. Kee
Drug Information Handbook / Vern Duba / Vicki R. Kee
Clinical Pharmacology / Vern Duba / Vicki R. Kee
Physicians' Desk Reference / Vern Duba / Vicki R. Kee
Textbooks / Vern Duba / Vicki R. Kee
Specialty References / Vern Duba / Vicki R. Kee
Drug Interactions / Vern Duba / Vicki R. Kee
Adverse Drug Reactions / Vern Duba / Vicki R. Kee
Pregnancy and Lactation / Vern Duba / Vicki R. Kee
Pediatrics / Vern Duba / Vicki R. Kee
Compatibility and Stability / Vern Duba / Vicki R. Kee
Natural Products / Vern Duba / Vicki R. Kee
Foreign Drugs / Vern Duba / Vicki R. Kee
Other Specialty Areas / Vern Duba / Vicki R. Kee
Electronic Applications / Vern Duba / Vicki R. Kee
Sources for Mobile Applications and Digital Information / Vicki R. Kee / Vern Duba
Summary / Vern Duba / Vicki R. Kee
References / Vern Duba / Vicki R. Kee
Introduction / Evelyn R. Hermes DeSantis / Luigi Brunetti
Search Strategy Issues / Evelyn R. Hermes DeSantis / Luigi Brunetti
Tree Structure / Evelyn R. Hermes DeSantis / Luigi Brunetti
Exploding the Hierarchy / Evelyn R. Hermes DeSantis / Luigi Brunetti
Focusing by Major Topic / Evelyn R. Hermes DeSantis / Luigi Brunetti
Subheadings / Evelyn R. Hermes DeSantis / Luigi Brunetti
Boolean Operators / Evelyn R. Hermes DeSantis / Luigi Brunetti
Review of Important Secondary Resources / Evelyn R. Hermes DeSantis / Luigi Brunetti
MEDLINE and PubMed / Evelyn R. Hermes DeSantis / Luigi Brunetti
Cumulative Index to Nursing and Allied Health / Evelyn R. Hermes DeSantis / Luigi Brunetti
International Pharmaceutical Abstracts / Evelyn R. Hermes DeSantis / Luigi Brunetti
Embase / Evelyn R. Hermes DeSantis / Luigi Brunetti
Google Scholar / Evelyn R. Hermes DeSantis / Luigi Brunetti
Web of Science / Evelyn R. Hermes DeSantis / Luigi Brunetti
Scopus / Evelyn R. Hermes DeSantis / Luigi Brunetti
Cochrane Library / Evelyn R. Hermes DeSantis / Luigi Brunetti
Other Specialty Resources / Evelyn R. Hermes DeSantis / Luigi Brunetti
Comparison of Secondary Resources / Evelyn R. Hermes DeSantis / Luigi Brunetti
Summary / Evelyn R. Hermes DeSantis / Luigi Brunetti
References / Evelyn R. Hermes DeSantis / Luigi Brunetti
Introduction / Joshua L. Conrad
Advantages and Disadvantages of Primary Literature / Joshua L. Conrad
Primary Literature Quality / Joshua L. Conrad
Peer Review / Joshua L. Conrad
Journal Affiliations / Joshua L. Conrad
Impact Factor / Joshua L. Conrad
Hirsch's /7Index / Joshua L. Conrad
Publication in Peer-Reviewed Journals / Joshua L. Conrad
Format of Original Research Articles / Joshua L. Conrad
Title/Authors / Joshua L. Conrad
Abstract / Joshua L. Conrad
Background / Joshua L. Conrad
Methods / Joshua L. Conrad
Results / Joshua L. Conrad
Discussion/Conclusion / Joshua L. Conrad
References / Joshua L. Conrad
Acknowledgments / Joshua L. Conrad
Using the Primary Literature / Joshua L. Conrad
Summary / Joshua L. Conrad
References / Joshua L. Conrad
Introduction / Joshua L. Conrad / Heather A. Pace
Study Hypotheses / Joshua L. Conrad / Heather A. Pace
Study Objectives / Joshua L. Conrad / Heather A. Pace
Primary Outcomes / Joshua L. Conrad / Heather A. Pace
Secondary Outcomes / Joshua L. Conrad / Heather A. Pace
Tertiary Outcomes / Joshua L. Conrad / Heather A. Pace
Safety Analyses / Joshua L. Conrad / Heather A. Pace
Subgroup Analyses / Joshua L. Conrad / Heather A. Pace
Past-Hoc Analyses / Joshua L. Conrad / Heather A. Pace
Outcome Measurement and Meaning / Joshua L. Conrad / Heather A. Pace
Precision and Accuracy / Joshua L. Conrad / Heather A. Pace
Negative and Positive Predictive Values / Joshua L. Conrad / Heather A. Pace
Sensitivity and Specificity / Joshua L. Conrad / Heather A. Pace
Surrogate and Direct Outcomes / Joshua L. Conrad / Heather A. Pace
Composite Outcomes / Joshua L. Conrad / Heather A. Pace
Types of Study Designs / Joshua L. Conrad / Heather A. Pace
Retrospective and Prospective Studies / Joshua L. Conrad / Heather A. Pace
Observational and Interventional (Experimental) Studies / Joshua L. Conrad / Heather A. Pace
Parallel, Matched, and Crossover Studies / Joshua L. Conrad / Heather A. Pace
Superiority, Equivalency, and Noninferiority Studies / Joshua L. Conrad / Heather A. Pace
Populations and Sampling / Joshua L. Conrad / Heather A. Pace
Probability (Random) Sampling / Joshua L. Conrad / Heather A. Pace
Nonprobability (Nonrandom) Sampling / Joshua L. Conrad / Heather A. Pace
Subject Criteria and Screening / Joshua L. Conrad / Heather A. Pace
Study Groups and Subject Allocation / Joshua L. Conrad / Heather A. Pace
Randomization Techniques / Joshua L. Conrad / Heather A. Pace
Blinding / Heather A. Pace / Joshua L. Conrad
Study Validity / Joshua L. Conrad / Heather A. Pace
Internal and External Validity / Joshua L. Conrad / Heather A. Pace
Ethics in Clinical Research / Joshua L. Conrad / Heather A. Pace
Principal Publications / Joshua L. Conrad / Heather A. Pace
Institutional Review Boards and Data Safety Monitoring Committees / Joshua L. Conrad / Heather A. Pace
Standards of Care / Joshua L. Conrad / Heather A. Pace
Informed Consent / Joshua L. Conrad / Heather A. Pace
Special Populations / Joshua L. Conrad / Heather A. Pace
Reporting Results / Joshua L. Conrad / Heather A. Pace
Summary / Joshua L. Conrad / Heather A. Pace
References / Joshua L. Conrad / Heather A. Pace
Introduction / Lara K. Ellinger
Descriptive Studies / Lara K. Ellinger
Case Reports and Case Series / Lara K. Ellinger
Cross-Sectional Studies / Lara K. Ellinger
Analytical Studies / Lara K. Ellinger
Observational Studies / Lara K. Ellinger
Interventional Studies and Randomized Controlled Trials / Lara K. Ellinger
Systematic Reviews and Meta-Analyses / Lara K. Ellinger
Systematic Reviews and Meta-Analyses in Evidence-Based Medicine / Lara K. Ellinger
Summary / Lara K. Ellinger
References / Lara K. Ellinger
Introduction / Jennifer Phillips / Kristina E. Ward
Variables: Dependent Versus Independent / Jennifer Phillips / Kristina E. Ward
Scales of Measurement / Jennifer Phillips / Kristina E. Ward
Measures of Central Tendency / Jennifer Phillips / Kristina E. Ward
Distribution of the Data / Jennifer Phillips / Kristina E. Ward
Normal Distribution / Jennifer Phillips / Kristina E. Ward
Probability Distributions / Jennifer Phillips / Kristina E. Ward
Measures of Variability / Jennifer Phillips / Kristina E. Ward
Variance and Standard Deviation / Jennifer Phillips / Kristina E. Ward
Standard Error of the Mean / Jennifer Phillips / Kristina E. Ward
Range and Interquartile Range / Jennifer Phillips / Kristina E. Ward
Methods of Data Presentation / Jennifer Phillips / Kristina E. Ward
Display of Qualitative (Discrete) Data / Jennifer Phillips / Kristina E. Ward
Display of Quantitative (Continuous) Data / Jennifer Phillips / Kristina E. Ward
Summary / Jennifer Phillips / Kristina E. Ward
References / Jennifer Phillips / Kristina E. Ward
Introduction / Erin M. Timpe Behnen / McKenzie C. Ferguson
Statistical Significance / Erin M. Timpe Behnen / McKenzie C. Ferguson
Contents note continued: Clinical Significance / Erin M. Timpe Behnen / McKenzie C. Ferguson
Choosing the Appropriate Statistical Test / Erin M. Timpe Behnen / McKenzie C. Ferguson
Parametric Versus Nonparametric Tests / Erin M. Timpe Behnen / McKenzie C. Ferguson
Types of Data / Erin M. Timpe Behnen / McKenzie C. Ferguson
Number of Samples / Erin M. Timpe Behnen / McKenzie C. Ferguson
Paired Versus Independent Data / McKenzie C. Ferguson / Erin M. Timpe Behnen
Confounding Variables / Erin M. Timpe Behnen / McKenzie C. Ferguson
One-Tailed Versus Two-Tailed Tests / Erin M. Timpe Behnen / McKenzie C. Ferguson
Common Statistical Tests by Data Type / Erin M. Timpe Behnen / McKenzie C. Ferguson
Tests for Continuous Data / Erin M. Timpe Behnen / McKenzie C. Ferguson
Tests for Ordinal Data / McKenzie C. Ferguson / Erin M. Timpe Behnen
Tests for Nominal Data / McKenzie C. Ferguson / Erin M. Timpe Behnen
Multiple Comparison Tests / Erin M. Timpe Behnen / McKenzie C. Ferguson
Summary / Erin M. Timpe Behnen / McKenzie C. Ferguson
References / Erin M. Timpe Behnen / McKenzie C. Ferguson
Introduction / Allison Bernknopf
Measurement in Epidemiological Studies / Allison Bernknopf
Incidence and Prevalence / Allison Bernknopf
Measures of Risk in Epidemiological Studies / Allison Bernknopf
Interpreting Relative Risks, Odds Ratios, Hazard Ratios, and Absolute Risks / Allison Bernknopf
Number Needed to Treat or Harm / Allison Bernknopf
What Measure of Associated Risk Should Be Presented? / Allison Bernknopf
Balancing Benefits and Harm / Allison Bernknopf
Calculating Risk Measures / Allison Bernknopf
Summary / Allison Bernknopf
References / Allison Bernknopf
Introduction / Joan Stachnik
Correlation and Regression / Joan Stachnik
Correlation / Joan Stachnik
Regression / Joan Stachnik
Summary / Joan Stachnik
References / Joan Stachnik
Introduction / Ryan Rodriguez
Concepts in Noninferiority Trial Design / Ryan Rodriguez
Null and Alternative Hypotheses of Noninferiority Trials Are "Reversed" from Superiority Trials / Ryan Rodriguez
Reasons for Noninferiority Trial Design / Ryan Rodriguez
Confidence Intervals and Reference Points / Ryan Rodriguez
Establishing Margins of Clinically Significant Differences / Ryan Rodriguez
Interpretation of Results in Noninferiority Trials / Ryan Rodriguez
Superiority Testing in Noninferiority Trials / Ryan Rodriguez
Designing and Evaluating the Noninferiority Hypothesis / Ryan Rodriguez
What Is the Effect of the Active Control Treatment? / Ryan Rodriguez
How Much Worse Can the Investigational Drug Be? / Ryan Rodriguez
Is the Investigational Drug Noninferior? / Ryan Rodriguez
Determining Noninferiority Margins in Trials That Report Absolute and Relative Risk Differences / Ryan Rodriguez
Systematic Biases in Noninferiority Trials / Ryan Rodriguez
Summary / Ryan Rodriguez
References / Ryan Rodriguez
Introduction / Joshua L. Conrad
Types of Error in Clinical Research / Joshua L. Conrad
Biases in Clinical Research / Joshua L. Conrad
Participation (Nonresponse) Bias and the Volunteer Effect / Joshua L. Conrad
Admission Rate (Berkson) Bias / Joshua L. Conrad
Prevalence-Incidence (Neyman) Bias / Joshua L. Conrad
Medical Surveillance Bias / Joshua L. Conrad
Detection Bias / Joshua L. Conrad
Procedure Selection Bias / Joshua L. Conrad
Membership Bias / Joshua L. Conrad
Response Bias / Joshua L. Conrad
Recall Bias / Joshua L. Conrad
Attention Bias, the Hawthorne Effect, and the Placebo Effect / Joshua L. Conrad
Exposure Suspicion Bias / Joshua L. Conrad
Unmasking Bias and Mimicry Bias / Joshua L. Conrad
Sample Size Bias / Joshua L. Conrad
Missing Data Bias and Withdrawal Bias / Joshua L. Conrad
Migration (Contamination) Bias / Joshua L. Conrad
Compliance (Adherence) Bias / Joshua L. Conrad
Scale Degradation Bias / Joshua L. Conrad
Reference Bias / Joshua L. Conrad
Rhetorical Bias / Joshua L. Conrad
Publication Bias / Joshua L. Conrad
Confounders in Clinical Research / Joshua L. Conrad
Chance in Clinical Research / Joshua L. Conrad
Alpha and p-Value / Joshua L. Conrad
Beta and Power / Joshua L. Conrad
Effect Size, Effect Variance, and Sample Size / Joshua L. Conrad
Retrospective Power / Joshua L. Conrad
Relationships Between Biases, Confounders, and Chance / Joshua L. Conrad
Summary / Joshua L. Conrad
References / Joshua L. Conrad
Introduction / Miki Goldwire / Jason Bobby
Practicing Evidence-Based Medicine / Miki Goldwire / Jason Bobby
Six-Step Process / Miki Goldwire / Jason Bobby
Step 1: Create an Answerable Clinical Question / Miki Goldwire / Jason Bobby
Step 2: Find the Best Evidence / Miki Goldwire / Jason Bobby
Experimental Designs: Randomized Controlled Trials / Miki Goldwire / Jason Bobby
Observational Studies / Miki Goldwire / Jason Bobby
Comparative Effectiveness Research and Pragmatic Trials / Miki Goldwire / Jason Bobby
Trials That Review Other Trials / Miki Goldwire / Jason Bobby
Searching the Literature / Miki Goldwire / Jason Bobby
Step 3: Critically Appraise the Evidence / Miki Goldwire / Jason Bobby
Step 1: Assess Internal Validity / Miki Goldwire / Jason Bobby
Step 2: Assess the Results / Jason Bobby / Miki Goldwire
Step 3: Assess Generalizability of the Results / Jason Bobby / Miki Goldwire
Step 4: Integrate Evidence with Clinical Judgment/Expertise and Patient Preferences / Miki Goldwire / Jason Bobby
Steps 5 and 6: Implement Intervention and Evaluate Effectiveness / Miki Goldwire / Jason Bobby
Clinical Practice Guidelines / Miki Goldwire / Jason Bobby
Types of Guidelines and Guideline Development / Jason Bobby / Miki Goldwire
Evaluating Guidelines / Miki Goldwire / Jason Bobby
Incorporating Guidelines into Practice / Jason Bobby / Miki Goldwire
Barriers to Guideline Use / Miki Goldwire / Jason Bobby
Locating Guidelines / Jason Bobby / Miki Goldwire
Barriers to Evidence-Based Medicine / Miki Goldwire / Jason Bobby
Limitations of Evidence-Based Medicine / Jason Bobby / Miki Goldwire
Publication Bias / Miki Goldwire / Jason Bobby
Randomized Controlled Trials and Dosing Recommendations / Jason Bobby / Miki Goldwire
Nature of Medicine / Miki Goldwire / Jason Bobby
Future of Evidence-Based Medicine / Jason Bobby / Miki Goldwire
Summary / Miki Goldwire / Jason Bobby
References / Miki Goldwire / Jason Bobby
Introduction / Dianne May / Jacquelyn Bryant
Define the Audience and Goals for the Journal Club / Dianne May / Jacquelyn Bryant
Professional Year 2 and 3 Students / Dianne May / Jacquelyn Bryant
Professional Year 4 Students / Dianne May / Jacquelyn Bryant
Residents and Practitioners / Dianne May / Jacquelyn Bryant
Drug Information Pharmacists and Educators / Dianne May / Jacquelyn Bryant
Choose a Designated Journal Club Coordinator and Define Other Roles / Dianne May / Jacquelyn Bryant
Journal Club Coordinator / Dianne May / Jacquelyn Bryant
Facilitator or Presenter / Dianne May / Jacquelyn Bryant
Content Expert / Dianne May / Jacquelyn Bryant
Participants / Dianne May / Jacquelyn Bryant
Consider the Best Location and Setting for the Journal Club / Dianne May / Jacquelyn Bryant
Classroom Setting / Dianne May / Jacquelyn Bryant
Small Group Discussion in a Conference Room or Office Setting / Dianne May / Jacquelyn Bryant
Patient Care Rounds Setting / Dianne May / Jacquelyn Bryant
Private Home, Restaurant, or Other Casual Setting / Jacquelyn Bryant / Dianne May
Virtual Journal Clubs / Jacquelyn Bryant / Dianne May
Select an Article and Format for the Journal Club / Jacquelyn Bryant / Dianne May
Critical Appraisal of a Single Article / Jacquelyn Bryant / Dianne May
Debate Format / Jacquelyn Bryant / Dianne May
Historical Perspective Format / Jacquelyn Bryant / Dianne May
Discuss Strengths and Weaknesses of a Particular Study Design / Jacquelyn Bryant / Dianne May
Evaluate the Journal Club / Jacquelyn Bryant / Dianne May
Summary / Jacquelyn Bryant / Dianne May
References / Jacquelyn Bryant / Dianne May
Introduction / Sherilyn VanOsdol
Medication Safety Terminology / Sherilyn VanOsdol
Why Errors Occur / Sherilyn VanOsdol
Human Error / Sherilyn VanOsdol
Systems Failures / Sherilyn VanOsdol
Culture of Safety / Sherilyn VanOsdol
How Errors Are Detected / Sherilyn VanOsdol
Quality Improvement in Medication Safety / Sherilyn VanOsdol
Root Cause Analysis / Sherilyn VanOsdol
Failure Modes and Effects Analysis / Sherilyn VanOsdol
External Reporting of Drug-Related Problems / Sherilyn VanOsdol
Risk Factors for Adverse Drug Events / Sherilyn VanOsdol
High-Risk Populations / Sherilyn VanOsdol
Care Settings / Sherilyn VanOsdol
Medication-Related Factors / Sherilyn VanOsdol
Medication Use Process / Sherilyn VanOsdol
Role of Health Information Technology / Sherilyn VanOsdol
Pharmacists' Roles in Promoting Medication Safety / Sherilyn VanOsdol
Interprofessional Teamwork / Sherilyn VanOsdol
Preventing Adverse Drug Events / Sherilyn VanOsdol
Medication Safety Leader / Sherilyn VanOsdol
Summary / Sherilyn VanOsdol
References / Sherilyn VanOsdol
Introduction / Catherine Brown / Keri C. Anderson
Contents note continued: How Medication Policies Are Developed and Written / Catherine Brown / Keri C. Anderson
Drivers for Development of a Medication Use Policy / Catherine Brown / Keri C. Anderson
Assessing Performance with Regard to Medication Policy / Catherine Brown / Keri C. Anderson
Operational Performance Assessment: Logs, Checklists, and Tracers / Catherine Brown / Keri C. Anderson
Clinical Performance Assessment: Medication Use Evaluation / Keri C. Anderson / Catherine Brown
Summary / Catherine Brown / Keri C. Anderson
References / Catherine Brown / Keri C. Anderson
Appendix 17-A IHI Model for Improvement / Catherine Brown / Keri C. Anderson
Appendix 17-B Example MUE Template / Catherine Brown / Keri C. Anderson
Appendix 17-C MUE Data Collection Form for Tapentadol / Catherine Brown / Keri C. Anderson
Appendix 17-D Example of MUE Results / Catherine Brown / Keri C. Anderson
Introduction / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
What Is a Formulary? / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
History and Evolution of Formularies / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Governance of a Formulary System / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Membership / Sabrina W. Cole / Kelli Garrison / Conor Hanrahan
Organization and Structure / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Strategies for Formulary Development / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Product Selection/Request Process / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Product Review / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Application of Literature Evaluation Skills / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Pharmacoeconomic Evaluation / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Strategies for Formulary Management / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Strategies for Formulary System Maintenance / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Nonformulary Use / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Role of Adverse Drug Reaction and Medication Error Surveillance and Reporting Programs / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Medication Use Policy Development / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Continuous Quality Improvement / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Medication Use Evaluations / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Special Considerations / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Off-Label Use / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Investigational Drug Use / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Procurement Challenges / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Effective Communication / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Summary / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
References / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Appendix 18-A Example of a Request to Change the Formulary / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Instructions / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Appendix 18-B Formulary Monograph Template / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Appendix 18-C Example of a Formulary Activity Checklist / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Appendix 18-D Example of Grading Levels of Evidence Worksheet / Sabrina W. Cole / Conor Hanrahan / Kelli Garrison
Introduction / Yvette Grando Holman / Michael Gabay
Academic Detailing / Yvette Grando Holman / Michael Gabay
Establishing an Academic Detailing Program / Yvette Grando Holman / Michael Gabay
Academic Detailing Programs on the State and Federal Levels / Yvette Grando Holman / Michael Gabay
Additional Resources / Yvette Grando Holman / Michael Gabay
Industry Relationships / Yvette Grando Holman / Michael Gabay
Current Pharmaceutical Industry Market / Yvette Grando Holman / Michael Gabay
Governance of Pharmaceutical Industry Relationships / Yvette Grando Holman / Michael Gabay
Structure of the Pharmaceutical Industry / Yvette Grando Holman / Michael Gabay
Pharmaceutical Buying Contracts / Yvette Grando Holman / Michael Gabay
Pharmaceutical Industry Provision of Education / Yvette Grando Holman / Michael Gabay
Opportunities to Partner with the Pharmaceutical Industry to Improve Patient Care / Yvette Grando Holman / Michael Gabay
Summary / Michael Gabay / Yvette Grando Holman
References / Yvette Grando Holman / Michael Gabay
Introduction / Maria G. Tanzi / Heather J. Ipema
Writing a Research Paper: Tips for Success / Maria G. Tanzi / Heather J. Ipema
Parts of a Manuscript / Maria G. Tanzi / Heather J. Ipema
Title / Maria G. Tanzi / Heather J. Ipema
Introduction / Maria G. Tanzi / Heather J. Ipema
Methods / Heather J. Ipema / Maria G. Tanzi
Results / Maria G. Tanzi / Heather J. Ipema
Discussion / Heather J. Ipema / Maria G. Tanzi
Abstract and Keywords / Heather J. Ipema / Maria G. Tanzi
References / Maria G. Tanzi / Heather J. Ipema
Ethical Issues in Medical Writing / Heather J. Ipema / Maria G. Tanzi
Manuscript Submission / Maria G. Tanzi / Heather J. Ipema
Selecting a Journal / Maria G. Tanzi / Heather J. Ipema
Manuscript Submission Process and Requirements / Heather J. Ipema / Maria G. Tanzi
Peer Review Process / Maria G. Tanzi / Heather J. Ipema
Purpose of Article Peer Review / Maria G. Tanzi / Heather J. Ipema
Reviewer Selection / Heather J. Ipema / Maria G. Tanzi
Review Process / Maria G. Tanzi / Heather J. Ipema
Peer Reviewer Ethics / Maria G. Tanzi / Heather J. Ipema
Summary / Maria G. Tanzi / Heather J. Ipema
References / Maria G. Tanzi / Heather J. Ipema
Introduction / Christine D. Sommer
History of Informatics / Christine D. Sommer
Meaningful Use / Christine D. Sommer
Clinical Decision Support and Medication Decision Support Data / Christine D. Sommer
Opportunities for Pharmacists / Christine D. Sommer
Summary / Christine D. Sommer
References / Christine D. Sommer
Introduction / Jennifer C. Samp / Yash J. Jalundhwala / Simon Pickard / Alexandra Perez
Economic Evaluations / Jennifer C. Samp / Yash J. Jalundhwala / Alexandra Perez / Simon Pickard
Components of Economic Evaluations / Jennifer C. Samp / Alexandra Perez / Yash J. Jalundhwala / Simon Pickard
Types of Economic Evaluations / Jennifer C. Samp / Yash J. Jalundhwala / Alexandra Perez / Simon Pickard
Decision Analysis / Alexandra Perez / Yash J. Jalundhwala / Jennifer C. Samp / Simon Pickard
Sensitivity Analyses / Jennifer C. Samp / Yash J. Jalundhwala / Alexandra Perez / Simon Pickard
Health-Related Quality of Life / Jennifer C. Samp / Yash J. Jalundhwala / Simon Pickard / Alexandra Perez
Comparative Effectiveness Research / Jennifer C. Samp / Yash J. Jalundhwala / Alexandra Perez / Simon Pickard
Economic Evaluation of Clinical Pharmacy Services / Jennifer C. Samp / Alexandra Perez / Yash J. Jalundhwala / Simon Pickard
Evaluating the Pharmacoeconomic Literature / Alexandra Perez / Yash J. Jalundhwala / Jennifer C. Samp / Simon Pickard
Future Challenges / Alexandra Perez / Yash J. Jalundhwala / Jennifer C. Samp / Simon Pickard
Acknowledgments / Jennifer C. Samp / Yash J. Jalundhwala / Alexandra Perez / Simon Pickard
Summary / Alexandra Perez / Yash J. Jalundhwala / Jennifer C. Samp / Simon Pickard
References / Jennifer C. Samp / Yash J. Jalundhwala / Alexandra Perez / Simon Pickard.